Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.34 -0.10 (-0.49%)
As of: Oct 21, 2026 · 10:41 AM EDT

Acadia Pharmaceuticals (ACAD) Current Assets (2010 - 2026)

Updated

Acadia Pharmaceuticals (ACAD) recorded Current Assets of $1.22 billion in Q2 2026, up 27.5% from $960.55 million a year earlier and up 11.7% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Acadia Pharmaceuticals reported Current Assets of $1.06 billion, up 13.2% from FY2024.

  • Annual Current Assets has increased for three straight years, with a five-year compound annual growth rate of 8.2% (FY2020 to FY2025).
  • Across earlier years, Current Assets came in at $938.32 million in FY2024 (+52.3%), $616.13 million in FY2023 (+21.3%), $507.94 million in FY2022 (-17.8%) and $617.82 million in FY2021 (-13.9%).
  • The Q2 2026 figure is the highest quarterly Current Assets in data going back to Q4 2010.
  • On a year-over-year basis, Current Assets has increased for 11 consecutive quarters, with growth averaging 34.3% over the last eight quarters.
  • Peak year-over-year performance for Current Assets in the last five years was growth of 57.9% in Q3 2024, against a decline of 19.5% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.1 billion (Q1 2026), $1.06 billion (Q4 2025) and $1.08 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,131.65 Bn 1,100.24 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 615.89 Bn 534.41 Bn 17.26 Bn 59.77 Bn
3 AbbVie 505.03 Bn 478.14 Bn 12.70 Bn 33.67 Bn
4 Merck 368.78 Bn 323.16 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 298.66 Bn 262.65 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 262.09 Bn 235.78 Bn 12.86 Bn 27.97 Bn
7 Amgen 236.57 Bn 191.97 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 191.05 Bn 165.25 Bn 6.22 Bn 13.95 Bn
9 Pfizer 170.60 Bn 117.25 Bn 10.94 Bn 41.36 Bn
10 Acadia Pharmaceuticals 3.49 Bn 17.48 Mn 279.64 Mn 1.22 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.22 Bn
Mar 31, 2026 1.10 Bn
Dec 31, 2025 1.06 Bn
Sep 30, 2025 1.08 Bn
Jun 30, 2025 960.55 Mn
Mar 31, 2025 870.94 Mn
Dec 31, 2024 938.32 Mn
Sep 30, 2024 788.28 Mn
Jun 30, 2024 728.92 Mn
Mar 31, 2024 675.30 Mn
Dec 31, 2023 616.13 Mn
Sep 30, 2023 499.17 Mn
Jun 30, 2023 492.63 Mn
Mar 31, 2023 502.85 Mn
Dec 31, 2022 507.94 Mn
Sep 30, 2022 521.55 Mn
Jun 30, 2022 532.52 Mn
Mar 31, 2022 542.22 Mn
Dec 31, 2021 617.82 Mn
Sep 30, 2021 640.92 Mn
API Access

Acadia Pharmaceuticals Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=ACAD&period=max&api_key=YOUR_API_KEY